McLaren C, Sibrack C D, Barry D W
Am J Med. 1982 Jul 20;73(1A):376-9. doi: 10.1016/0002-9343(82)90126-7.
HSV-1 and HSV-2 clinical isolates were tested for their in vitro sensitivity to acyclovir. The median ID50 for 32 genital HSV-2 isolates was 0.215 micrograms/ml and this was not significantly higher than a median value of 0.125 micrograms/ml for 28 oral HSV-1 isolates (p = 0.08). A wider range of ID50s was observed with the HSV-2 isolates compared with the HSV-1 isolates. The concentration of drug required to inhibit virus replication by 90 and 99 percent was approximately 10- and 100-fold greater than that producing 50 percent inhibition.
对单纯疱疹病毒1型(HSV - 1)和单纯疱疹病毒2型(HSV - 2)的临床分离株进行了阿昔洛韦的体外敏感性测试。32株生殖器HSV - 2分离株的半数感染剂量(ID50)中位数为0.215微克/毫升,这并不显著高于28株口腔HSV - 1分离株0.125微克/毫升的中位数(p = 0.08)。与HSV - 1分离株相比,HSV - 2分离株观察到更广泛的ID50范围。抑制病毒复制90%和99%所需的药物浓度分别比产生50%抑制作用时所需浓度高约10倍和100倍。